- Home
- BRN vs MIRA Comparison
BRN vs MIRA Comparison
Compare BRN & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRN
- MIRA
- Stock Information
- Founded
- BRN 1956
- MIRA 2020
- Country
- BRN United States
- MIRA United States
- Employees
- BRN N/A
- MIRA N/A
- Industry
- BRN Oil & Gas Production
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- BRN Energy
- MIRA Health Care
- Exchange
- BRN Nasdaq
- MIRA Nasdaq
- Market Cap
- BRN 17.6M
- MIRA 20.5M
- IPO Year
- BRN N/A
- MIRA 2023
- Fundamental
- Price
- BRN $1.62
- MIRA $0.95
- Analyst Decision
- BRN
- MIRA Strong Buy
- Analyst Count
- BRN 0
- MIRA 2
- Target Price
- BRN N/A
- MIRA $14.00
- AVG Volume (30 Days)
- BRN 20.4K
- MIRA 360.9K
- Earning Date
- BRN 05-13-2025
- MIRA 05-12-2025
- Dividend Yield
- BRN N/A
- MIRA N/A
- EPS Growth
- BRN N/A
- MIRA N/A
- EPS
- BRN N/A
- MIRA N/A
- Revenue
- BRN $20,046,000.00
- MIRA N/A
- Revenue This Year
- BRN N/A
- MIRA N/A
- Revenue Next Year
- BRN N/A
- MIRA N/A
- P/E Ratio
- BRN N/A
- MIRA N/A
- Revenue Growth
- BRN N/A
- MIRA N/A
- 52 Week Low
- BRN $1.26
- MIRA $0.51
- 52 Week High
- BRN $3.20
- MIRA $5.01
- Technical
- Relative Strength Index (RSI)
- BRN 48.22
- MIRA 38.16
- Support Level
- BRN $1.26
- MIRA $1.06
- Resistance Level
- BRN $1.79
- MIRA $1.29
- Average True Range (ATR)
- BRN 0.08
- MIRA 0.11
- MACD
- BRN -0.00
- MIRA -0.02
- Stochastic Oscillator
- BRN 33.33
- MIRA 4.74
About BRN Barnwell Industries Inc.
Barnwell Industries Inc is an oil and gas firm. Its areas of operations include acquiring, developing, producing, and selling oil and natural gas. The company acquires and develops crude oil and natural gas assets. The company's operating segment includes Oil and natural gas, Contract drilling, Land investment, and Others. It generates maximum revenue from the Oil and natural gas segment. It operates in two geographical segments the United States, which generates a majority of revenue, and Canada.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.